Abstract
The effect of PCA on motility was investigated after s.c. injection to rats in a familiar cage. The doses 1, 2, 5 and 10 mg/kg induced increasing hypermotility. PCA 1 and 2 mg/kg produced various normal behavioral items, but 5 and 10 mg/kg induced mainly abnormal jerky locomotion and head movements.
The effect of PCA 5 mg/kg was investigated in rats treated s.c. with various drugs affecting central monoamines. Pretreatment with the 5HT-synthesis inhibitor H 69/17 200 mg/kg, the tyrosinehydroxylase inhibitor H 44/68 250 mg/kg twice and reserpine 7.5 mg/kg inhibited PCA-hyperactivity. H 44/68 250 mg/kg once and the dopamine Β-hydroxylase inhibitor FLA 63 did not influence the effect of PCA.
Simultaneous administration of imipramine 3.1 mg/kg, chlorimipramine 0.9 mg/kg, desipramine 26 mg/kg, amitriptyline 15 mg/kg, doxepine 1.8 mg/kg, chlorpromazine 0.1 mg/kg, haloperidol 0.01 mg/kg, spiramide 0.01 mg/kg and chlorpheniramine 3.9 mg/kg antagonized PCA-hypermotility. Protriptyline 50 mg/kg, clozapine 20 mg/kg and benztropine 10 mg/kg showed no PCA-antagonism.
These results indicate that 5HT and DA release are involved in PCA-hyperactivity and that 5HT-membrane blockers inhibit uptake of PCA into brain 5HT neurons thus preventing 5HT release.
Similar content being viewed by others
References
Andén, N.-E., Corrodi, H., Fuxe, K.: Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine-Β-hydroxylase inhibitors. J. Pharm. Pharmacol. 24, 177–182 (1972)
Arnfred, T., Randrup, A.: Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour. Acta pharmacol. (Kbh.) 26, 384–394 (1968)
Bindra, D., Blond, J.: A time-sample method for measuring general activity and its components. Canad. J. Physiol. 12, 74–76 (1958)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine. Europ. J. Pharmacol. 5, 367–373 (1969a)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine. Europ. J. Pharmacol. 5, 357–366 (1969b)
Carlsson, A., Fuxe, K., Hamberger, B., Lindqvist, M.: Biochemical and histochemical studies on the effects of imipramine-like and (+)-amphetamine on central and peripheral catecholamine neurons. Acta physiol. scand. 67, 481–497 (1966)
Carlsson, A., Fuxe, K., Ungerstedt, U.: The effect of imipramine on central 5-hydroxytryptamine neurons. J. Pharm. Pharmacol. 20, 150–151 (1968)
Carlsson, A., Jonason, J., Lindqvist, M., Fuxe, K.: Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res. 12, 456–460 (1969c)
Carlsson, A., Lindqvist, M.: Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesiscs and antihistamines. J. Pharm. Pharmacol. 21, 460–464 (1969)
Corrodi, H., Fuxe, K., Ljungdahl, å., ögren, S.-O.: Studies on the action of some psychoactive drugs on central noradrenaline neurones after inhibition of dopamine-Β-hydroxylase. Brain Res. 24, 451–470 (1970)
Dingell, J. V., Owens, M. L., Norvich, M. R., Sulser, F.: On the role of norepinephrine biosynthesis in the central action of amphetamine. Life Sci. 6, 1155–1162 (1967)
Dominic, J. A., Moore, K. E.: Acute effects of α-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice. Arch. int. Pharmacodyn. 178, 166–176 (1969)
Ernst, A. M.: Mode of Action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967)
Frey, H.-H., Magnussen, M. P.: Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue. Biochem. Pharmacol. 17, 1299–1307 (1968)
Fuller, R. W., Hines, C. W., Mills, J.: Lowering of brain serotonin level by chloramphetamines. Biochem. Pharmacol. 14, 483–488 (1965)
Fuxe, K., Ungerstedt, U.: Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamines. Europ. J. Phamacol. 4, 135–144 (1968)
Hanson, L. C. F.: Evidence that the central action of (+)-amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.) 10, 289–297 (1967)
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L.: Is it possible to predict the clinical effects of neuroleptic drugs (Major Tranquillizers) from animal data? Arzneimittel-Forsch. 15, 104–125 (1965)
Jéquier, E., Lovenberg, W., Sjoerdsma, A.: Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Molec. Pharmacol. 3, 274–278 (1967)
Klawans, H. L.: The pharmacology of parkinsonism. Dis. nerv. Syst. 29, 805–816 (1968)
Koe, B. Kenneth, Weissman, A.: p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–516 (1966)
Lidbrink, P., Jonsson, G., Fue, K.: The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology 10, 521–536 (1971)
Miller, F. P., Cox, R. H., Snodgras, W. R., Maickel, R. P.: Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19, 435–442 (1970)
NybÄck, H.: Regional disappearance of catecholamines formed from 14C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine. Acta pharmacol. (Kbh.) 30, 372–384 (1971)
Peters, D. A. V., Filczewski, M., Mazurkiewicz-Kwilecki, I. M.: Effect of parachlorophenylalanine on catecholamine synthesis in rat brain, heart and adrenals. Biochem. Pharmacol. 21, 2282–2284 (1972)
Pfeifer, A. K., György, L., Fodor, M.: Role of catecholamines in the central effects of amphetamine. Acta med. Acad. Sci. hung. 25, 441–450 (1968)
Pletscher, A., Prada, M. Da, Burkard, W. P., Bartholini, G., Steiner, F. A., Bruderer, H., Bigler, F.: Aralkylamines with different effects on the metabolism of aromatic monoamines. J. Pharmacol. exp. Ther. 154, 64–72 (1966)
Posehel, B. P. H., Ninteman, F. W.: Intracranial reward and the forebrain's serotoninergic mechanism: studies employing para-chlorophenylalanine and parachloroamphetamine. Physiol. Behav. 7, 39–46 (1971)
Prescott, R. G. W.: Some behavioural effects of variables which influence the “general level of activity” of rats. Anim. Behav. 18, 791–796 (1970)
Randrup, A., Munkvad, I.: Role of catecholamines in the amphetamine excitatory response. Nature (Lond.) 211, 540 (1966)
Randrup, A., Munkvad, I., Udsen, P.: Adrenergic mechanisms and amphetamine induced abnormal behaviour. Acta pharmacol. (Kbh.) 20, 145–157 (1963)
Sanders-Bush, E., Sulser, F.: p-Chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin. J. Pharmacol. exp. Ther. 175, 419–426 (1970)
Sanders-Bush, E., Bushing, J. A., Sulser, F.: Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain. Europ. J. Pharmacol. 20, 385–388 (1972)
Scheel-Krüger, J.: Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic antidepressant drugs. Europ. J. Pharmacol. 18, 63–73 (1972)
Scheel-Krüger, J.: Central effects of anticholinergic drugs measured by the apomorphine gnawing test in mice. Acta pharmacol. (Kbh.) 28, 1–16 (1970)
Scheel-Krüger, J.: Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Europ. J. Pharmacol. 14, 47–59 (1971)
Scheel-Krüger, J.: Studies on the accumulation of o-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone. Arch. int. Pharmacodyn. 195, 372–378 (1972)
Schelkunov, E. L.: Integrated effect of psychotropic drugs on the balance of cholinoadreno-, and serotoninergic processes in the brain as a basis of their gross behavioral and therapeutic actions. Activ. nerv. sup. (Praha) 9, 207–217 (1967)
Squires, R.: Antagonism of p-chloroamphetamine (PCA) induced depletion of 5-HT from rat brain by some thymoleptics and other psychotropic drugs. Acta pharmacol. (Kbh.) 31, suppl. 1, 35 (1972)
Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (Clozapine). Farmaco. Ed. prat. 26, 603–625 (1971)
Stolk, J. M., Rech, R. H.: Antagonism of d-amphetamine by alphamethyl-l-tyrosine: Behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response. Neuropharmacology 9, 249–263 (1970)
Strada, S. J., Sanders-Bush, E., Sulser, F.: p-chloroamphetamine temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine. Biochem. Pharmacol. 19, 2621–2629 (1970)
Strada, S. J., Sulser, F.: Comparative effects of p-chloroamphetamine and amphetamine on metabolism and in vivo release of 3H-norepinephrine in the hypothalamus. Europ. J. Pharmacol. 15, 45–51 (1971)
Sulser, F., Owens, M. L., Norwich, M. R., Dingell, J. V.: The relative role of storage and synthesis of brain norepinephrine in the psychomotor stimulation evoked by amphetamine or by desipramine and tetrabenazine. Psychopharmacologia (Berl.) 12, 322–332 (1968)
Svensson, T. H., Thieme, G.: An investigation of a new instrument to measure motor activity of small animals. Psychopharmacologia (Berl.) 14, 157–163 (1969)
Svensson, T. H., Waldeck, B.: On the significance of central noradrenaline for motor activity: experiments with a new dopamine-Β-hydroxylase inhibitor. Europ. J. Pharmacol. 7, 278–282 (1969)
Ursillo, R. C., McCulloch, J. A.: The effect of Elantrine, a new anti-parkinsonism agent, on drug-induced tremor in mice. Arch. int. Pharmacodyn. 197, 132–140 (1972)
Volicer, L.: Correlation between behavioral and biochemical effects of p-chlorophenylalanine in mice and rats. Int. J. Neuropharmacol. 8, 361–364 (1969)
Weisman, A., Koe, B. K., Tenen, S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 151, 339–352 (1966)
Wong, D. T., Horng, J.-S., Fuller, R. W.: Kinetics of serotonin accumulation into synaptosomes of rat brain-effects of amphetamine and chloroamphetamines. Biochem. Pharmacol. 22, 311–322 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lassen, J.B. The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction. Psychopharmacologia 34, 243–254 (1974). https://doi.org/10.1007/BF00421965
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421965